Inside Access, Outside the Rules - Summary - MDSpire

Inside Access, Outside the Rules

Two federal cases highlight alleged misuse of professional roles in health care settings

  • By

  • Kerri Miller

  • April 1, 2026

  • 3 min

Share

Objective:

To report on recent indictments related to pharmacy and telemedicine fraud.

Key Findings:
  • Abbott is accused of illegally obtaining controlled substances like Adderall and oxycodone.
  • Harwood's scheme involved aggressive telemarketing to Medicare patients for unnecessary medical items, including orthotic braces and genetic tests.
  • Harwood faces restitution of $17.9 million and up to 20 years in prison.
Interpretation:

These cases highlight significant risks of fraud in both pharmacy and telemedicine sectors, emphasizing the need for stringent oversight.

Limitations:
  • Abbott has not been convicted and is presumed innocent until proven guilty.
  • Details on the full extent of the fraud schemes may not be fully disclosed until further legal proceedings, which could reveal additional information.
Conclusion:

The cases illustrate vulnerabilities in healthcare systems, particularly in telemedicine, where oversight can lag behind rapid service expansion.

Original Source(s)

Inside Access, Outside the Rules

  • by Kerri Miller

  • April 1, 2026

Related Content

Stewardship Cuts Steroid Prescribing

Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing

Medical Oddities: Something Viral is Lurking in the Dust

Everyday things like yawns, tea, dust, and kimchi suddenly look medically important.

Inflammation Tied to Organ Failure Risk

Review outlines mechanisms, prognosis, and supportive care strategies in surgical and trauma ICU populations